In Reply Foster et al make the point that our analysis “should not be used in clinical practice to frame the potential benefits of solid-organ transplant.” We agree entirely. It is not an analysis that determines the survival benefit for an individual patient in the current era. Instead, it looks at what has been accomplished in the field of solid-organ transplantation. Excluding less than 1.6% of patients listed for solid-organ transplant, it is an inclusive study that simply follows up with everyone using the Social Security Death Master Files. Our analysis looks at the collective survival benefit of the entire group over 25 years. It is not a study for individual patients and not for clinical use in the current era.
Rana A, Gruessner A, Gruessner RWG. Estimation of Life-Years Saved by Solid-Organ Transplant—Reply. JAMA Surg. 2015;150(10):1015–1016. doi:10.1001/jamasurg.2015.1939
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: